Crossmark

INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol

Crossref DOI link: https://doi.org/10.1186/s13063-019-3993-0

Published Online: 2019-12-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moga, Daniela C. http://orcid.org/0000-0002-3648-8197
Beech, Brooke F.

Abner, Erin L.

Schmitt, Frederick A.

El Khouli, Riham H.

Martinez, Ashley I.

Eckmann, Lynne

Huffmyer, Mark

George, Rosmy

Jicha, Gregory A.
Funding

Funding for this research was provided by:

National Institute on Aging (R01 AG054130)

Foundation for the National Institutes of Health (UL1TR000117)
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-30
More Information

Article History

Received: 6 October 2019

Accepted: 11 December 2019

First Online: 30 December 2019

Ethics approval and consent to participate

: The study was approved by the Institutional Review Board at University of Kentucky (IRB #43239) and all participants provide signed informed consent for participation.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below